Mawson Infrastructure
MIGI
Bitdeer Technologies
BTDR
MARA Holdings
MARA
BTCS Inc
BTCS
Abits
ABTS
US Stock MarketDetailed Quotes
MRK Merck & Co
- 90.580
- +1.200+1.34%
Close Feb 27 16:00 ET
- 90.200
- -0.380-0.42%
Post 19:28 ET
228.81BMarket Cap13.44P/E (TTM)
90.970High89.250Low10.72MVolume89.350Open89.380Pre Close968.06MTurnover0.43%Turnover Ratio13.44P/E (Static)2.53BShares132.67152wk High4.94P/B228.45BFloat Cap81.04052wk Low3.12Dividend TTM2.52BShs Float132.671Historical High3.44%Div YieldTTM1.92%Amplitude17.857Historical Low90.331Avg Price1Lot Size
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Merck & Co Stock Forum
Can Merck's KEYTRUDA Transform Head and Neck Cancer Treatment After 20-Year Stagnation?
As I've been suggesting recently, this sell-off was likely to occur for a couple of key reasons. We’ve had a round of bad news, so we are awaiting good news to break us higher. But traders are bracing for dis...
Esperion Therapeutics (ESPR), currently trading under $2 per share, has been attracting considerable attention from analysts. Recently, three analysts reaffirmed strong "Buy" ratings, with price targets ranging from $5 to $16 per share. Among the nine analysts covering Esperion, seven h...
less than 60s, big whale swallowed it
No comment yet